NCT04055766

Brief Summary

DeepDoc is an AI-based decision support system for the early etiology diagnosis of neurological diseases using clinical data points from patients admitted to hospital within 24 hours.This study aims to evaluate whether the diagnosis of the DeepDoc AI-based decision support system is better than the doctor's initial diagnosis by a multi-center, superiority diagnostic study.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 14, 2019

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

December 13, 2019

Status Verified

July 1, 2019

Enrollment Period

8 days

First QC Date

August 4, 2019

Last Update Submit

December 11, 2019

Conditions

Keywords

Artificial Intelligence

Outcome Measures

Primary Outcomes (1)

  • Accuracy of diagnosis by DeepDoc AI-based Decision Support System

    Accuracy of diagnosis by DeepDoc and compare this result with doctors

    24 hours

Secondary Outcomes (2)

  • Sensitivity of diagnosis by DeepDoc AI-based Decision Support System

    24 hours

  • Specificity of diagnosis by DeepDoc AI-based Decision Support System

    24 hours

Study Arms (4)

Meningitis/Encephalitis

Patients with clinical signs and symptoms suspected of meningitis/encephalitis

Device: DeepDoc AI-based Decision Support System

Stroke

Patients with clinical signs and symptoms suspected of stroke

Device: DeepDoc AI-based Decision Support System

Headache

Patients with clinical signs and symptoms suspected of headache

Device: DeepDoc AI-based Decision Support System

Vertigo

Patients with clinical signs and symptoms suspected of vertigo

Device: DeepDoc AI-based Decision Support System

Interventions

Patients are diagnosed by the DeepDoc within 24 hours of admission.

HeadacheMeningitis/EncephalitisStrokeVertigo

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

4000 consecutive patients suspected of stroke,meningitis/encephalitis, vertigo and headache(1000 cases of each disease) are admitted to the department of neurology that consented to involvement in the study.

You may qualify if:

  • Patients with clinical symptoms or signs suspected of stroke,meningitis/encephalitis, vertigo and headache.
  • Neurological examination results and imaging changes within 24 hours of admission.

You may not qualify if:

  • Patients discharged, transferred to the hospital, or died within 24 hours after admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

StrokeHeadacheVertigoMeningitisEncephalitis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsVestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNeuroinflammatory Diseases

Study Officials

  • Zhao Gang

    Xijing Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2019

First Posted

August 14, 2019

Study Start

September 1, 2020

Primary Completion

September 9, 2020

Study Completion

March 1, 2021

Last Updated

December 13, 2019

Record last verified: 2019-07